# AlloVir Inc. (ALVR)

Source: https://www.quantisnow.com/company/ALVR
Generated: 2026-11-09T21:02:55.259Z

- Ticker: ALVR
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2020
- Website: allovir.com

## About

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is Viralym-M, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. Its preclinical and clinical development product candidates include ALVR106 for respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108 to treat human herpesvirus-8, including Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's diseases. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was founded in 2013 and is based in Cambridge, Massachusetts.

## Latest ALVR news and filings

- 2025-03-27 23:19 UTC [SEC Form 4] [Chief Accounting Officer Hagen Brett R sold $8,135 worth of shares (907 units at $8.97), decreasing direct ownership by 32% to 1,925 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-accounting-officer-hagen-brett-r-sold-8135-worth-of-5963833)
- 2025-03-26 21:06 UTC [SEC Form 3] [Amendment: New insider Akkaraju Srinivas claimed ownership of 3,578 shares (SEC Form 3)](https://www.quantisnow.com/insight/amendment-new-insider-akkaraju-srinivas-claimed-ownership-of-3578-shares-5961601)
- 2025-03-25 23:40 UTC [SEC Form SCHEDULE 13D filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13d-filed-by-allovir-inc-5960060)
- 2025-03-25 23:38 UTC [SEC Form 3] [New insider Samsara Biocapital Gp, Llc claimed ownership of 11,448,081 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-samsara-biocapital-gp-llc-claimed-ownership-of-11448081-5960057)
- 2025-03-20 20:32 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by AlloVir Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-allovir-inc-5954619)
- 2025-03-18 21:45 UTC [SEC Form 4] [Director Ferrara Napoleone was granted 504,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-ferrara-napoleone-was-granted-504000-shares-sec-form-4-5950704)
- 2025-03-18 21:44 UTC [SEC Form 4] [Director Patel Samir Chandrakant was granted 352,800 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-patel-samir-chandrakant-was-granted-352800-shares-sec-form-5950701)
- 2025-03-18 21:43 UTC [SEC Form 4] [Chief Medical Officer Feinsod Matthew was granted 4,030 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-medical-officer-feinsod-matthew-was-granted-4030-shares-sec-5950692)
- 2025-03-18 21:41 UTC [SEC Form 4] [SEC Form 4 filed by Officer Oxtoby Andrew](https://www.quantisnow.com/insight/sec-form-4-filed-by-officer-oxtoby-andrew-5950681)
- 2025-03-18 21:40 UTC [SEC Form 4] [Director Akkaraju Srinivas was granted 11,444,503 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-akkaraju-srinivas-was-granted-11444503-shares-sec-form-4-5950680)
- 2025-03-18 21:37 UTC [SEC Form 4] [SEC Form 4 filed by Director Adamis Anthony P](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-adamis-anthony-p-5950672)
- 2025-03-18 21:30 UTC [SEC Form 3] [SEC Form 3 filed by new insider Akkaraju Srinivas](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-akkaraju-srinivas-5950635)
- 2025-03-18 21:27 UTC [SEC Form 3] [SEC Form 3 filed by new insider Ferrara Napoleone](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-ferrara-napoleone-5950602)
- 2025-03-18 21:25 UTC [SEC Form 3] [SEC Form 3 filed by new insider Dybbs Michael](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-dybbs-michael-5950576)
- 2025-03-18 21:21 UTC [SEC Form 3] [SEC Form 3 filed by new insider Patel Samir Chandrakant](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-patel-samir-chandrakant-5950554)
- 2025-03-18 21:20 UTC [SEC Form 3] [SEC Form 3 filed by new insider Oxtoby Andrew](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-oxtoby-andrew-5950543)
- 2025-03-18 21:17 UTC [SEC Form 3] [SEC Form 3 filed by new insider Feinsod Matthew](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-feinsod-matthew-5950532)
- 2025-03-18 21:14 UTC [SEC Form 3] [SEC Form 3 filed by new insider Adamis Anthony P](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-adamis-anthony-p-5950490)
- 2025-03-18 21:04 UTC [SEC Form 8-K] [AlloVir Inc. filed SEC Form 8-K: Financial Statements and Exhibits, Leadership Update, Completion of Acquisition or Disposition of Assets, Changes in Control of Registrant, Regulation FD Disclosure](https://www.quantisnow.com/insight/allovir-inc-filed-sec-form-8-k-financial-statements-and-exhibits-5950388)
- 2025-03-12 20:18 UTC [SEC Form 8-K] [SEC Form 8-K filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-allovir-inc-5940870)
- 2025-03-07 12:30 UTC [SEC Form 10-K] [SEC Form 10-K filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-allovir-inc-5932463)
- 2025-02-28 21:09 UTC [SEC Form 424B3] [SEC Form 424B3 filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-allovir-inc-5917297)
- 2025-02-24 21:15 UTC [SEC Form 4] [Officer Sinha Vikas sold $3,053 worth of shares (303 units at $10.08), decreasing direct ownership by 0.61% to 49,129 units (SEC Form 4)](https://www.quantisnow.com/insight/officer-sinha-vikas-sold-3053-worth-of-shares-303-units-5905411)
- 2025-02-24 21:15 UTC [SEC Form 4] [General Counsel Miller Edward sold $1,068 worth of shares (106 units at $10.08), decreasing direct ownership by 2% to 6,517 units (SEC Form 4)](https://www.quantisnow.com/insight/general-counsel-miller-edward-sold-1068-worth-of-shares-106-5905407)
- 2025-02-24 21:15 UTC [SEC Form 4] [Chief Accounting Officer Hagen Brett R sold $967 worth of shares (96 units at $10.08), decreasing direct ownership by 3% to 2,832 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-accounting-officer-hagen-brett-r-sold-967-worth-of-5905406)
- 2025-02-24 16:56 UTC [SEC Form 144] [SEC Form 144 filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-allovir-inc-5904804)
- 2025-02-24 16:55 UTC [SEC Form 144] [SEC Form 144 filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-allovir-inc-5904802)
- 2025-02-24 16:51 UTC [SEC Form 144] [SEC Form 144 filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-allovir-inc-5904799)
- 2025-02-14 18:17 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by AlloVir Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-allovir-inc-5889856)
- 2025-02-11 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-allovir-inc-5880817)
- 2025-02-10 21:19 UTC [SEC Form 424B3] [SEC Form 424B3 filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-allovir-inc-5879869)
- 2025-02-03 21:59 UTC [SEC Form S-4] [Amendment: SEC Form S-4/A filed by AlloVir Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-4a-filed-by-allovir-inc-5867851)
- 2025-01-27 21:16 UTC [SEC Form 4] [General Counsel Miller Edward sold $494 worth of shares (52 units at $9.50), decreasing direct ownership by 0.78% to 6,623 units (SEC Form 4)](https://www.quantisnow.com/insight/general-counsel-miller-edward-sold-494-worth-of-shares-52-5858248)
- 2025-01-27 21:15 UTC [SEC Form 4] [Chief Accounting Officer Hagen Brett R sold $342 worth of shares (36 units at $9.51), decreasing direct ownership by 1% to 2,928 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-accounting-officer-hagen-brett-r-sold-342-worth-of-5858234)
- 2025-01-27 21:11 UTC [SEC Form 4] [Officer Sinha Vikas sold $1,226 worth of shares (129 units at $9.50), decreasing direct ownership by 0.26% to 49,432 units (SEC Form 4)](https://www.quantisnow.com/insight/officer-sinha-vikas-sold-1226-worth-of-shares-129-units-5858182)
- 2025-01-24 20:03 UTC [SEC Form 144] [SEC Form 144 filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-allovir-inc-5856509)
- 2025-01-24 19:55 UTC [SEC Form 144] [SEC Form 144 filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-allovir-inc-5856506)
- 2025-01-24 19:51 UTC [SEC Form 144] [SEC Form 144 filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-allovir-inc-5856503)
- 2025-01-17 21:11 UTC [SEC Form S-4] [Amendment: SEC Form S-4/A filed by AlloVir Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-4a-filed-by-allovir-inc-5849892)
- 2025-01-15 21:41 UTC [SEC Form 425] [SEC Form 425 filed by AlloVir Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-allovir-inc-5847265)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ALVR
- Earnings history: https://www.quantisnow.com/earnings/ALVR
- Dividend history: https://www.quantisnow.com/dividends/ALVR
- Insider transactions: https://www.quantisnow.com/insiders/ALVR
- Options chain: https://www.quantisnow.com/options/ALVR
- SEC 8-K filings only: https://www.quantisnow.com/company/ALVR/8-k
- RSS and alerts for ALVR: https://www.quantisnow.com/docs/rss-feeds.md